Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Eur J Haematol. 2018 Oct 9;101(6):798–803. doi: 10.1111/ejh.13173

Figure 3:

Figure 3:

Effects of α-thalassemia on RBC deformability measured at 290 mmosmol/l (DI 290) after excluding those under HU therapy. Alpha-thalassaemic group: n = 31; No alpha-thalassaemia group: n = 60. Difference between groups: *p < 0.05.